Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year



Acq - P2P | Acquired

Total Raised




About Sagent Pharmaceuticals

Sagent Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.

Sagent Pharmaceuticals Headquarter Location

1901 N Roselle Road

Schaumburg, Illinois, 60195,

United States


Latest Sagent Pharmaceuticals News

Carcinoid Syndrome Management Market Financial Guide for 2027 by Leading Players- Sun Pharmaceutical Industries Limited, Sagent Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd.

Jun 23, 2021

Search jobs 23-Jun-2021 Carcinoid Syndrome Management Market Financial Guide for 2027 by Leading Players- Sun Pharmaceutical Industries Limited, Sagent Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd. FutureMarket Insights (FMI) adopted a multidisciplinary approach during thepandemic-era to focus on the growth and development of the CarcinoidSyndrome Management Market . The study features insights on thecurrent growth dynamics and the major revenue reforms prevailing in the marketas of 2020 along with the key takeaways over the forecast period. Impact ofCOVID-19 on the Healthcare Industry The COVID-19pandemic has caused severe impacts on the global economy at various levels andwhich can be seen on the Healthcare industry as well. The thriving market ofhealth care research and development is expected to exhibit a steep decline inthe sales during the lockdown period owing to the shutdown of the manufacturingunits, acute shortage in the supply of raw materials and absence of potentialmanpower. It can be deduced from the current situations brought about by thepandemic that the production, and supply chain activities have experiencedminor hurdles. However, the market is projected to gradually recoverpost-COVID-19, which will present attractive opportunities for sales acrossvarious regions of the world in the following years. The teamof analysts at Future Business Insights are focussing on research and marketstudy to produce different Carcinoid Syndrome Management Market forecasts andpredictions at both national and international levels. They have consideredseveral leads of information pertaining to the industry like market figures andmerger estimations to assess and produce reliable and informative insights onthe Carcinoid Syndrome Management Market. Ask an Analyst @ KeyPlayers Some of the major players in the global carcinoid syndrome managementmarket are Novartis International AG (Sandoz), Pharmascience Inc., OmegaLaboratories Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., IpsenBiopharmaceuticals, Inc., Sirtex Medical Limited, BTG International Ltd. amongothers. Companies that provide generic chemotherapeutic agents includeWockhardt Ltd., Sun Pharmaceutical Industries Limited, Sagent Pharmaceuticals,Inc., Sun Pharmaceutical Industries Ltd. etc. Segmentation       Tentatively, the global carcinoidsyndrome management market has been segmented on the basis of treatment type,distribution channel, and geography. Based on Treatment type, theglobal carcinoid syndrome management market is divided into following: Chemotherapy QueriesSolved What arethe key segments and sub-segments in the market? What arethe key drivers, restraints, opportunities, and challenges of the CarcinoidSyndrome Management Market in the Healthcare Industry, and how they areexpected to impact the market? What arethe attractive investment opportunities within the Carcinoid SyndromeManagement Market in the Healthcare Industry? What isthe Carcinoid Syndrome Management Market in the Healthcare Industry size at theregional and country-level? What arethe key market players focusing on? What arethe strategies for growth adopted by the key players in Carcinoid SyndromeManagement Market in the Healthcare Industry? What arethe recent trends in Carcinoid Syndrome Management Market in the HealthcareIndustry? (M&A, partnerships, new product developments, expansions)? What arethe challenges to the Carcinoid Syndrome Management Market in the growth of theHealthcare Industry? What arethe key market trends impacting the growth of the Carcinoid Syndrome ManagementMarket in the Healthcare Industry? Ask for TOC @ Reasonsto buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking services market,despite undergoing a temporary period of lull due to COVID-19 outbreak, islikely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sagent Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sagent Pharmaceuticals is included in 2 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.



5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.